Regeneron’s COVID-19 Antibody Cocktail Shows 8-Month Preventative Protection

November 8, 2021

A single dose of Regeneron’s COVID-19 antibody cocktail, REGEN-COV, slashed the risk of contracting the coronavirus by 81.6 percent up to eight months after treatment in a phase 3 trial.
Source: Drug Industry Daily

Posted in Drug Industry Daily